Aberrant epigenetic regulation in breast cancer

Patho-Epigenetics of Disease

Volumn 9781461433453, Issue , 2012, Pages 91-122

  Toland, Amanda Ewart ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84919830922     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4614-3345-3_5     Document Type: Chapter

References (145)

1. Agrawal, A., Murphy, R. F. & Agrawal, D. K. (2007). DNA methylation in breast and colorectal cancers. Mod Pathol 20, 711-721.
2. Ai, L., Kim, W. J., Demircan, B., Dyer, L. M., Bray, K. J., Skehan, R. R., Massoll, N. A. & Brown, K. D. (2008). The transglutaminase 2 gene (TGM2), a potential molecular marker for chemotherapeutic drug sensitivity, is epigenetically silenced in breast cancer. Carcinogenesis 29, 510-518.
3. Al Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J. & Clarke, M. F. (2003). Prospective identi fication of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 100, 3983-3988.
4. Alford, S. H., Toy, K., Merajver, S. D. & Kleer, C. G. (2012). Increased risk for distant metastasis in patients with familial early-stage breast cancer and high EZH2 expression. Breast Cancer Res Treat 132, 429-437.
5. Allen, N. E., Beral, V., Casabonne, D., Kan, S. W., Reeves, G. K., Brown, A. & Green, J. (2009). Moderate alcohol intake and cancer incidence in women. J Natl Cancer Inst 101, 296-305.
6. Avril-Sassen, S., Goldstein, L. D., Stingl, J., Blenkiron, C., Le Quesne, J., Spiteri, I., Karagavriilidou, K., Watson, C. J., Tavare, S., Miska, E. A. & Caldas, C. (2009). Characterisation of microRNA expression in post-natal mouse mammary gland development. BMC Genomics 10:548.
7. Bae, Y. K., Brown, A., Garrett, E., Bornman, D., Fackler, M. J., Sukumar, S., Herman, J. G. & Gabrielson, E. (2004). Hypermethylation in histologically distinct classes of breast cancer. Clin Cancer Res 10, 5998-6005.
8. Ballestar, E. & Esteller, M. (2005). Methyl-CpG-binding proteins in cancer: blaming the DNA methylation messenger. Biochem Cell Biol 83, 374-384.
9. Bannister, A. J. & Kouzarides, T. (2011). Regulation of chromatin by histone modi fications. Cell Res 21, 381-395.
10. Bloushtain-Qimron, N., Yao, J., Shipitsin, M., Maruyama, R. & Polyak, K. (2009). Epigenetic patterns of embryonic and adult stem cells. Cell Cycle 8, 809-817.
11. Bloushtain-Qimron, N., Yao, J., Snyder, E. L., Shipitsin, M., Campbell, L. L., Mani, S. A., Hu, M., Chen, H., Ustyansky, V., Antosiewicz, J. E., Argani, P., Halushka, M. K., Thomson, J. A., Pharoah, P., Porgador, A., Sukumar, S., Parsons, R., Richardson, A. L., Stampfer, M. R., Gelman, R. S., Nikolskaya, T., Nikolsky, Y. & Polyak, K. (2008). Cell type-specific DNA methylation patterns in the human breast. Proc Natl Acad Sci U S A 105, 14076-14081.
12. Bolden, J. E., Peart, M. J. & Johnstone, R. W. (2006). Anticancer activities of histone deacetylase inhibitors. Nat Rev Drug Discov 5, 769-784.
13. Bollati, V., Schwartz, J., Wright, R., Litonjua, A., Tarantini, L., Suh, H., Sparrow, D., Vokonas, P. & Baccarelli, A. (2009). Decline in genomic DNA methylation through aging in a cohort of elderly subjects. Mech Ageing Dev 130, 234-239.
14. Bombonati, A. & Sgroi, D. C. (2011). The molecular pathology of breast cancer progression. J Pathol 223, 307-317.
15. Bromer, J. G., Zhou, Y., Taylor, M. B., Doherty, L. & Taylor, H. S. (2010). Bisphenol-A exposure in utero leads to epigenetic alterations in the developmental programming of uterine estrogen response. FASEB J 24, 2273-2280.
16. Catteau, A. & Morris, J. R. (2002). BRCA1 methylation: a signi ficant role in tumour development? Semin Cancer Biol 12, 359-371.
17. Chase, A. & Cross, N. C. (2011). Aberrations of EZH2 in cancer. Clin Cancer Res 17, 2613-2618.
18. Chedin, F. (2011). The DNMT3 family of mammalian de novo DNA methyltransferases. Prog Mol Biol Transl Sci 101, 255-285.
19. Cheng, A. S., Culhane, A. C., Chan, M. W., Venkataramu, C. R., Ehrich, M., Nasir, A., Rodriguez, B. A., Liu, J., Yan, P. S., Quackenbush, J., Nephew, K. P., Yeatman, T. J. & Huang, T. H. (2008). Epithelial progeny of estrogen-exposed breast progenitor cells display a cancer-like methylome. Cancer Res 68, 1786-1796.
20. Cheng, J., Guo, J. M., Xiao, B. X., Miao, Y., Jiang, Z., Zhou, H. & Li, Q. N. (2011). piRNA, the new non-coding RNA, is aberrantly expressed in human cancer cells. Clin Chim Acta 412, 1621-1625.
21. Cheng, J. C., Yoo, C. B., Weisenberger, D. J., Chuang, J., Wozniak, C., Liang, G., Marquez, V. E., Greer, S., Orntoft, T. F., Thykjaer, T. & Jones, P. A. (2004). Preferential response of cancer cells to zebularine. Cancer Cell 6, 151-158.
22. Choi, J. Y., James, S. R., Link, P. A., McCann, S. E., Hong, C. C., Davis, W., Nesline, M. K., Ambrosone, C. B. & Karpf, A. R. (2009). Association between global DNA hypomethylation in leukocytes and risk of breast cancer. Carcinogenesis 30, 1889-1897.
23. Christensen, B. C., Kelsey, K. T., Zheng, S., Houseman, E. A., Marsit, C. J., Wrensch, M. R., Wiemels, J. L., Nelson, H. H., Karagas, M. R., Kushi, L. H., Kwan, M. L. & Wiencke, J. K. (2010). Breast cancer DNA methylation profiles are associated with tumor size and alcohol and folate intake. PLoS Genet 6, e1001043.
24. Colaneri, A., Staffa, N., Fargo, D. C., Gao, Y., Wang, T., Peddada, S. D. & Birnbaumer, L. (2011). Expanded methyl-sensitive cut counting reveals hypomethylation as an epigenetic state that highlights functional sequences of the genome. Proc Natl Acad Sci U S A 108, 9715-9720.
25. Cotton, A. M., Lam, L., Affleck, J. G., Wilson, I. M., Penaherrera, M. S., McFadden, D. E., Kobor, M. S., Lam, W. L., Robinson, W. P. & Brown, C. J. (2011). Chromosome-wide DNA methylation analysis predicts human tissue-specific X inactivation. Hum Genet 130, 187-201.
26. Daskalos, A., Nikolaidis, G., Xinarianos, G., Savvari, P., Cassidy, A., Zakopoulou, R., Kotsinas, A., Gorgoulis, V., Field, J. K. & Liloglou, T. (2009). Hypomethylation of retrotransposable elements correlates with genomic instability in non-small cell lung cancer. Int J Cancer 124, 81-87.
27. Dejeux, E., Ronneberg, J. A., Solvang, H., Bukholm, I., Geisler, S., Aas, T., Gut, I. G., Borresen-Dale, A. L., Lonning, P. E., Kristensen, V. N. & Tost, J. (2010). DNA methylation profiling in doxorubicin treated primary locally advanced breast tumours identifies novel genes associated with survival and treatment response. Mol Cancer 9:68.
28. Deniaud, E. & Bickmore, W. A. (2009). Transcription and the nuclear periphery: edge of darkness? Curr Opin Genet Dev 19, 187-191.
29. Dietrich, D., Krispin, M., Dietrich, J., Fassbender, A., Lewin, J., Harbeck, N., Schmitt, M., Eppenberger-Castori, S., Vuaroqueaux, V., Spyratos, F., Foekens, J. A., Lesche, R. & Martens, J. W. (2010). CDO1 promoter methylation is a biomarker for outcome prediction of anthracycline treated, estrogen receptor-positive, lymph node-positive breast cancer patients. BMC Cancer 10:247.
30. Dolinoy, D. C., Huang, D. & Jirtle, R. L. (2007). Maternal nutrient supplementation counteracts bisphenol A-induced DNA hypomethylation in early development. Proc Natl Acad Sci U S A 104, 13056-13061.
31. Dostie, J., Richmond, T. A., Arnaout, R. A., Selzer, R. R., Lee, W. L., Honan, T. A., Rubio, E. D., Krumm, A., Lamb, J., Nusbaum, C., Green, R. D. & Dekker, J. (2006). Chromosome Conformation Capture Carbon Copy (5C): a massively parallel solution for mapping interactions between genomic elements. Genome Res 16, 1299-1309.
32. Ehrlich, M. (2000). DNA hypomethylation and cancer. In DNA Alterations in Cancer, pp. 273-291. Edited by M. Ehrlich. Westborough: Eaton Publishing.
33. Ehrlich, M. (2009). DNA hypomethylation in cancer cells. Epigenomics 1, 239-259.
34. Elsheikh, S. E., Green, A. R., Rakha, E. A., Powe, D. G., Ahmed, R. A., Collins, H. M., Soria, D., Garibaldi, J. M., Paish, C. E., Ammar, A. A., Grainge, M. J., Ball, G. R., Abdelghany, M. K., Martinez-Pomares, L., Heery, D. M. & Ellis, I. O. (2009). Global histone modi fications in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome. Cancer Res 69, 3802-3809.
35. Enerly, E., Steinfeld, I., Kleivi, K., Leivonen, S. K., Aure, M. R., Russnes, H. G., Ronneberg, J. A., Johnsen, H., Navon, R., Rodland, E., Makela, R., Naume, B., Perala, M., Kallioniemi, O., Kristensen, V. N., Yakhini, Z. & Borresen-Dale, A. L. (2011). miRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumors. PLoS ONE 6, e16915.
36. Fang, F., Turcan, S., Rimner, A., Kaufman, A., Giri, D., Morris, L. G., Shen, R., Seshan, V., Mo, Q., Heguy, A., Baylin, S. B., Ahuja, N., Viale, A., Massague, J., Norton, L., Vahdat, L. T., Moynahan, M. E. & Chan, T. A. (2011). Breast cancer methylomes establish an epigenomic foundation for metastasis. Sci Transl Med 3, 75ra25.
37. Fassan, M., Baffa, R., Palazzo, J. P., Lloyd, J., Crosariol, M., Liu, C. G., Volinia, S., Alder, H., Rugge, M., Croce, C. M. & Rosenberg, A. (2009). MicroRNA expression profiling of male breast cancer. Breast Cancer Res 11:R58.
38. Fazzari, M. J. & Greally, J. M. (2010). Introduction to epigenomics and epigenome-wide analysis. Methods Mol Biol 620, 243-265.
39. Feinberg, A. P. & Vogelstein, B. (1983). Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 301, 89-92.
40. Fiegl, H., Millinger, S., Mueller-Holzner, E., Marth, C., Ensinger, C., Berger, A., Klocker, H., Goebel, G. & Widschwendter, M. (2005). Circulating tumor-specific DNA: a marker for monitoring efficacy of adjuvant therapy in cancer patients. Cancer Res 65, 1141-1145.
41. Flanagan, J. M., Cocciardi, S., Waddell, N., Johnstone, C. N., Marsh, A., Henderson, S., Simpson, P., Da Silva, L., Khanna, K., Lakhani, S., Boshoff, C. & Chenevix-Trench, G. (2010). DNA methylome of familial breast cancer identifies distinct profiles defined by mutation status. Am J Hum Genet 86, 420-433.
42. Flanagan, L., Packman, K., Juba, B., O'Neill, S., Tenniswood, M. & Welsh, J. (2003). Efficacy of Vitamin D compounds to modulate estrogen receptor negative breast cancer growth and invasion. J Steroid Biochem Mol Biol 84, 181-192.
43. Fleming, J. L., Huang, T. H. & Toland, A. E. (2008). The role of parental and grandparental epigenetic alterations in familial cancer risk. Cancer Res 68, 9116-9121.
44. Fletcher, A. M., Heaford, A. C. & Trask, D. K. (2008). Detection of metastatic head and neck squamous cell carcinoma using the relative expression of tissue-specific mir-205. Transl Oncol 1, 202-208.
45. Fouse, S. D., Nagarajan, R. P. & Costello, J. F. (2010). Genome-scale DNA methylation analysis. Epigenomics 2, 105-117.
46. Fraga, M. F., Ballestar, E., Paz, M. F., Ropero, S., Setien, F., Ballestar, M. L., Heine-Suner, D., Cigudosa, J. C., Urioste, M., Benitez, J., Boix-Chornet, M., Sanchez-Aguilera, A., Ling, C., Carlsson, E., Poulsen, P., Vaag, A., Stephan, Z., Spector, T. D., Wu, Y. Z., Plass, C. & Esteller, M. (2005a). Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci U S A 102, 10604-10609.
47. Fraga, M. F., Ballestar, E., Villar-Garea, A., Boix-Chornet, M., Espada, J., Schotta, G., Bonaldi, T., Haydon, C., Ropero, S., Petrie, K., Iyer, N. G., Perez-Rosado, A., Calvo, E., Lopez, J. A., Cano, A., Calasanz, M. J., Colomer, D., Piris, M. A., Ahn, N., Imhof, A., Caldas, C., Jenuwein, T. & Esteller, M. (2005b). Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nat Genet 37, 391-400.
48. Fraga, M. F. & Esteller, M. (2002). DNA methylation: a pro file of methods and applications. Biotechniques 33, 632-639.
49. Fuino, L., Bali, P., Wittmann, S., Donapaty, S., Guo, F., Yamaguchi, H., Wang, H. G., Atadja, P. & Bhalla, K. (2003). Histone deacetylase inhibitor LAQ824 down-regulates Her-2 and sensitizes human breast cancer cells to trastuzumab, taxotere, gemcitabine, and epothilone B. Mol Cancer Ther 2, 971-984.
50. Fullgrabe, J., Kavanagh, E. & Joseph, B. (2011). Histone onco-modifications. Oncogene 30, 3391-3403.
51. Gaudet, M. M., Campan, M., Figueroa, J. D., Yang, X. R., Lissowska, J., Peplonska, B., Brinton, L. A., Rimm, D. L., Laird, P. W., Garcia-Closas, M. & Sherman, M. E. (2009). DNA hypermethylation of ESR1 and PGR in breast cancer: pathologic and epidemiologic associations. Cancer Epidemiol Biomarkers Prev 18, 3036-3043.
52. Ginger, M. R., Shore, A. N., Contreras, A., Rijnkels, M., Miller, J., Gonzalez-Rimbau, M. F. & Rosen, J. M. (2006). A noncoding RNA is a potential marker of cell fate during mammary gland development. Proc Natl Acad Sci U S A 103, 5781-5786.
53. Guffanti, A., Iacono, M., Pelucchi, P., Kim, N., Soldà, G., Croft, L. J., Taft, R. J., Rizzi, E., Askarian-Amiri, M., Bonnal, R. J., Callari, M., Mignone, F., Pesole, G., Bertalot, G., Bernardi, L. R., Albertini, A., Lee, C., Mattick, J. S., Zucchi, I., & De Bellis, G. A. (2009). A transcriptional sketch of a primary human breast cancer by 454 sequencing. BMC Genomics 10, 163.
54. Guffei, A., Sarkar, R., Klewes, L., Righolt, C., Knecht, H. & Mai, S. (2010). Dynamic chromosomal rearrangements in Hodgkin's lymphoma are due to ongoing three-dimensional nuclear remodeling and breakage-bridge-fusion cycles. Haematologica 95, 2038-2046.
55. Gupta, R. A., Shah, N., Wang, K. C., Kim, J., Horlings, H. M., Wong, D. J., Tsai, M. C., Hung, T., Argani, P., Rinn, J. L., Wang, Y., Brzoska, P., Kong, B., Li, R., West, R. B., Van De Vijver, M. J., Sukumar, S. & Chang, H. Y. (2010). Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 464, 1071-1076.
56. Hamajima, N., Hirose, K., Tajima, K., Rohan, T., Calle, E. E., Heath, C. W., Jr., Coates, R. J., Liff, J. M., Talamini, R., Chantarakul, N., Koetsawang, S., Rachawat, D., Morabia, A., Schuman, L., Stewart, W., Szklo, M., Bain, C., Schofield, F., Siskind, V., Band, P., Coldman, A. J., Gallagher, R. P., Hislop, T. G., Yang, P., Kolonel, L. M., Nomura, A. M., Hu, J., Johnson, K. C., Mao, Y., De Sanjose, S., Lee, N., Marchbanks, P., Ory, H. W., Peterson, H. B., Wilson, H. G., Wingo, P. A., Ebeling, K., Kunde, D., Nishan, P., Hopper, J. L., Colditz, G., Gajalanski, V., Martin, N., Pardthaisong, T., Silpisornkosol, S., Theetranont, C., Boosiri, B., Chutivongse, S., Jimakorn, P., Virutamasen, P., Wongsrichanalai, C., Ewertz, M., Adami, H. O., Bergkvist, L., Magnusson, C., Persson, I., Chang-Claude, J., Paul, C., Skegg, D. C., Spears, G. F., Boyle, P., Evstifeeva, T., Daling, J. R., Hutchinson, W. B., Malone, K., Noonan, E. A., Stanford, J. L., Thomas, D. B., Weiss, N. S., White, E., Andrieu, N., Bremond, A., Clavel, F., Gairard, B., Lansac, J., Piana, L., Renaud, R., Izquierdo, A., Viladiu, P., Cuevas, H. R., Ontiveros, P., Palet, A., Salazar, S. B., Aristizabel, N., Cuadros, A., Tryggvadottir, L., Tulinius, H., Bachelot, A., Le, M. G., Peto, J., Franceschi, S., Lubin, F., Modan, B., Ron, E., Wax, Y., Friedman, G. D., Hiatt, R. A., Levi, F., Bishop, T., Kosmelj, K., Primic-Zakelj, M., Ravnihar, B., Stare, J., Beeson, W. L., Fraser, G., Bullbrook, R. D., Cuzick, J., Duffy, S. W., Fentiman, I. S., Hayward, J. L., Wang, D. Y., McMichael, A. J., McPherson, K., Hanson, R. L., Leske, M. C., Mahoney, M. C., Nasca, P. C., Varma, A. O., Weinstein, A. L., Moller, T. R., Olsson, H., Ranstam, J., Goldbohm, R. A., Van Den Brandt, P. A., Apelo, R. A., Baens, J., De, L. C., Jr., Javier, B., Lacaya, L. B., Ngelangel, C. A., La Vecchia, C., Negri, E., Marubini, E., Ferraroni, M., Gerber, M., Richardson, S., Segala, C., Gatei, D., Kenya, P., Kungu, A., Mati, J. G., Brinton, L. A., Hoover, R., Schairer, C., Spirtas, R., Lee, H. P., Rookus, M. A., Van Leeuwen, F. E., Schoenberg, J. A., McCredie, M., Gammon, M. D., Clarke, E. A., Jones, L., Neil, A., Vessey, M., Yeates, D., Appleby, P., Banks, E., Beral, V., Bull, D., Crossley, B., Goodill, A., Green, J., Hermon, C., Key, T., Langston, N., Lewis, C., Reeves, G., Collins, R., Doll, R., Peto, R., Mabuchi, K., Preston, D., Hannaford, P., Kay, C., Rosero-Bixby, L., Gao, Y. T., Jin, F., Yuan, J. M., Wei, H. Y., Yun, T., Zhiheng, C., Berry, G., Cooper, B. J., Jelihovsky, T., MacLennan, R., Shearman, R., Wang, Q. S., Baines, C. J., Miller, A. B., Wall, C., Lund, E., Stalsberg, H., Shu, X. O., Zheng, W., Katsouyanni, K., Trichopoulou, A., Trichopoulos, D., Dabancens, A., Martinez, L., Molina, R., Salas, O., Alexander, F. E., Anderson, K., Folsom, A. R., Hulka, B. S., Bernstein, L., Enger, S., Haile, R. W., Paganini-Hill, A., Pike, M. C., Ross, R. K., Ursin, G., Yu, M. C., Longnecker, M. P., Newcomb, P., Bergkvist, L., Kalache, A., Farley, T. M., Holck, S. & Meirik, O. (2002). Alcohol, tobacco and breast cancer-collaborative reanalysis of individual data from 53 epidemiological studies, including 58, 515 women with breast cancer and 95, 067 women without the disease. Br J Cancer 87, 1234-1245.
57. Hannafon, B. N., Sebastiani, P., De Las, M. A., Lu, J. & Rosenberg, C. L. (2011). Expression of microRNA and their gene targets are dysregulated in preinvasive breast cancer. Breast Cancer Res 13, R24.
58. Hansen, K. D., Timp, W., Bravo, H. C., Sabunciyan, S., Langmead, B., McDonald, O. G., Wen, B., Wu, H., Liu, Y., Diep, D., Briem, E., Zhang, K., Irizarry, R. A. & Feinberg, A. P. (2011). Increased methylation variation in epigenetic domains across cancer types. Nat Genet 43, 768-775.
59. Heaphy, C. M., Griffith, J. K. & Bisoffi, M. (2009). Mammary field cancerization: molecular evidence and clinical importance. Breast Cancer Res Treat 118, 229-239.
60. Henikoff, S. (2008). Nucleosome destabilization in the epigenetic regulation of gene expression. Nat Rev Genet 9, 15-26.
61. Heride, C., Ricoul, M., Kieu, K., Von Hase, J., Guillemot, V., Cremer, C., Dubrana, K. & Sabatier, L. (2010). Distance between homologous chromosomes results from chromosome positioning constraints. J Cell Sci 123, 4063-4075.
62. Hermann, A., Goyal, R. & Jeltsch, A. (2004). The Dnmt1 DNA-(cytosine-C5)-methyltransferase methylates DNA processively with high preference for hemimethylated target sites. J Biol Chem 279, 48350-48359.
63. Hernandez-Vargas, H., Ouzounova, M., Calvez-Kelm, F., Lambert, M. P., McKay-Chopin, S., Tavtigian, S. V., Puisieux, A., Matar, C. & Herceg, Z. (2011). Methylome analysis reveals Jak-STAT pathway deregulation in putative breast cancer stem cells. Epigenetics 6, 428-439.
64. Hinshelwood, R. A. & Clark, S. J. (2008). Breast cancer epigenetics: normal human mammary epithelial cells as a model system. J Mol Med (Berl) 86, 1315-1328.
65. Hirst, M. & Marra, M. A. (2010). Next generation sequencing based approaches to epigenomics. Brief Funct Genomics 9, 455-465.
66. Hsu, P. Y., Deatherage, D. E., Rodriguez, B. A., Liyanarachchi, S., Weng, Y. I., Zuo, T., Liu, J., Cheng, A. S. & Huang, T. H. (2009). Xenoestrogen-induced epigenetic repression of microRNA-9-3 in breast epithelial cells. Cancer Res 69, 5936-5945.
67. Hsu, P. Y., Hsu, H. K., Singer, G. A., Yan, P. S., Rodriguez, B. A., Liu, J. C., Weng, Y. I., Deatherage, D. E., Chen, Z., Pereira, J. S., Lopez, R., Russo, J., Wang, Q., Lamartiniere, C. A., Nephew, K. P. & Huang, T. H. (2010). Estrogen-mediated epigenetic repression of large chromosomal regions through DNA looping. Genome Res 20, 733-744.
68. Huang, T. H. & Esteller, M. (2010). Chromatin remodeling in mammary gland differentiation and breast tumorigenesis. Cold Spring Harb Perspect Biol 2, a004515.
69. Hurst, D. R., Edmonds, M. D. & Welch, D. R. (2009). Metastamir: the field of metastasis-regulatory microRNA is spreading. Cancer Res 69, 7495-7498.
70. Iorio, M. V., Casalini, P., Piovan, C., Di Leva, G., Merlo, A., Triulzi, T., Menard, S., Croce, C. M. & Tagliabue, E. (2009). microRNA-205 regulates HER3 in human breast cancer. Cancer Res 69, 2195-2200.
71. Jing, M. X., Mao, X. Y., Li, C., Wei, J., Liu, C. & Jin, F. (2011). Estrogen receptor-alpha promoter methylation in sporadic basal-like breast cancer of Chinese women. Tumour Biol 32, 713-719.
72. Jintaridth, P. & Mutirangura, A. (2010). Distinctive patterns of age-dependent hypomethylation in interspersed repetitive sequences. Physiol Genomics 41, 194-200.
73. Jovanovic, J., Ronneberg, J. A., Tost, J. & Kristensen, V. (2010). The epigenetics of breast cancer. Mol Oncol 4, 242-254.
74. Kabotyanski, E. B., Rijnkels, M., Freeman-Zadrowski, C., Buser, A. C., Edwards, D. P. & Rosen, J. M. (2009). Lactogenic hormonal induction of long distance interactions between beta-casein gene regulatory elements. J Biol Chem 284, 22815-22824.
75. Kanwar, J. R., Mahidhara, G. & Kanwar, R. K. (2011). Antiangiogenic therapy using nanotechnological-based delivery system. Drug Discov Today 16, 188-202.
76. Key, J., Hodgson, S., Omar, R. Z., Jensen, T. K., Thompson, S. G., Boobis, A. R., Davies, D. S. & Elliott, P. (2006). Meta-analysis of studies of alcohol and breast cancer with consideration of the methodological issues. Cancer Causes Control 17, 759-770.
77. Khalil, A. M., Guttman, M., Huarte, M., Garber, M., Raj, A., Rivea, M. D., Thomas, K., Presser, A., Bernstein, B. E., Van Oudenaarden, A., Regev, A., Lander, E. S. & Rinn, J. L. (2009). Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci U S A 106, 11667-11672.
78. Kim, S. J., Kim, T. W., Lee, S. Y., Park, S. J., Kim, H. S., Chung, K. W., Lee, E. S. & Kang, H. S. (2004). CpG methylation of the ERalpha and ERbeta genes in breast cancer. Int J Mol Med 14, 289-293.
79. Kornberg, R. D. & Lorch, Y. (1999). Twenty-five years of the nucleosome, fundamental particle of the eukaryote chromosome. Cell 98, 285-294.
80. Lapidus, R. G., Ferguson, A. T., Ottaviano, Y. L., Parl, F. F., Smith, H. S., Weitzman, S. A., Baylin, S. B., Issa, J. P. & Davidson, N. E. (1996). Methylation of estrogen and progesterone receptor gene 5' CpG islands correlates with lack of estrogen and progesterone receptor gene expression in breast tumors. Clin Cancer Res 2, 805-810.
81. Le Quesne, J. & Caldas, C. (2010). Micro-RNAs and breast cancer. Mol Oncol 4, 230-241.
82. Lehmann, U., Hasemeier, B., Christgen, M., Muller, M., Romermann, D., Langer, F. & Kreipe, H. (2008). Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer. J Pathol 214, 17-24.
83. Lehmann, U., Streichert, T., Otto, B., Albat, C., Hasemeier, B., Christgen, H., Schipper, E., Hille, U., Kreipe, H. H. & Langer, F. (2010). Identi fication of differentially expressed microRNAs in human male breast cancer. BMC Cancer 10:109.
84. Leygue, E. (2007). Steroid receptor RNA activator (SRA1): unusual bifaceted gene products with suspected relevance to breast cancer. Nucl Recept Signal 5, e006.
85. Li, S., Hansman, R., Newbold, R., Davis, B., McLachlan, J. A. & Barrett, J. C. (2003). Neonatal diethylstilbestrol exposure induces persistent elevation of c-fos expression and hypomethylation in its exon-4 in mouse uterus. Mol Carcinog 38, 78-84.
86. Lin, Y. W., Chen, H. M. & Fang, J. Y. (2011). Gene silencing by the Polycomb group proteins and associations with cancer. Cancer Invest 29, 187-195.
87. Lister, R., Pelizzola, M., Dowen, R. H., Hawkins, R. D., Hon, G., Tonti-Filippini, J., Nery, J. R., Lee, L., Ye, Z., Ngo, Q. M., Edsall, L., Antosiewicz-Bourget, J., Stewart, R., Ruotti, V., Millar, A. H., Thomson, J. A., Ren, B. & Ecker, J. R. (2009). Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 19, 315-322.
88. Lo, P. K. & Sukumar, S. (2008). Epigenomics and breast cancer. Pharmacogenomics 9, 1879-1902.
89. Lodygin, D., Tarasov, V., Epanchintsev, A., Berking, C., Knyazeva, T., Korner, H., Knyazev, P., Diebold, J. & Hermeking, H. (2008). Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer. Cell Cycle 7, 2591-2600.
90. Lopez-Serra, L. & Esteller, M. (2008). Proteins that bind methylated DNA and human cancer: reading the wrong words. Br J Cancer 98, 1881-1885.
91. Ma, L., Young, J., Prabhala, H., Pan, E., Mestdagh, P., Muth, D., Teruya-Feldstein, J., Reinhardt, F., Onder, T. T., Valastyan, S., Westermann, F., Speleman, F., Vandesompele, J. & Weinberg, R. A. (2010). miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol 12, 247-256.
92. Markey, C. M., Luque, E. H., Munoz, D. T., Sonnenschein, C. & Soto, A. M. (2001). In utero exposure to bisphenol A alters the development and tissue organization of the mouse mammary gland. Biol Reprod 65, 1215-1223.
93. Markou, A., Tsaroucha, E. G., Kaklamanis, L., Fotinou, M., Georgoulias, V. & Lianidou, E. S. (2008). Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR. Clin Chem 54, 1696-1704.
94. Marotta, L. L., Almendro, V., Marusyk, A., Shipitsin, M., Schemme, J., Walker, S. R., Bloushtain-Qimron, N., Kim, J. J., Choudhury, S. A., Maruyama, R., Wu, Z., Gonen, M., Mulvey, L. A., Bessarabova, M. O., Huh, S. J., Silver, S. J., Kim, S. Y., Park, S. Y., Lee, H. E., Anderson, K. S., Richardson, A. L., Nikolskaya, T., Nikolsky, Y., Liu, X. S., Root, D. E., Hahn, W. C., Frank, D. A. & Polyak, K. (2011). The JAK2/STAT3 signaling pathway is required for growth of CD44CD24 stem cell-like breast cancer cells in human tumors. J Clin Invest 121, 2723-2735.
95. Matilainen, J. M., Malinen, M., Turunen, M. M., Carlberg, C. & Vaisanen, S. (2010). The number of vitamin D receptor binding sites defines the different vitamin D responsiveness of the CYP24 gene in malignant and normal mammary cells. J Biol Chem 285, 24174-24183.
96. Meaburn, K. J., Gudla, P. R., Khan, S., Lockett, S. J. & Misteli, T. (2009). Disease-specific gene repositioning in breast cancer. J Cell Biol 187, 801-812.
97. Moelans, C. B., Verschuur-Maes, A. H. & Van Diest, P. J. (2011). Frequent promoter hypermethylation of BRCA2, CDH13, MSH6, PAX5, PAX6 and WT1 in ductal carcinoma in situ and invasive breast cancer. J Pathol 225, 222-231.
98. Muller, H. M., Widschwendter, A., Fiegl, H., Ivarsson, L., Goebel, G., Perkmann, E., Marth, C. & Widschwendter, M. (2003). DNA methylation in serum of breast cancer patients: an independent prognostic marker. Cancer Res 63, 7641-7645.
99. Nair, S. S., Coolen, M. W., Stirzaker, C., Song, J. Z., Statham, A. L., Strbenac, D., Robinson, M. W. & Clark, S. J. (2011). Comparison of methyl-DNA immunoprecipitation (MeDIP) and methyl-CpG binding domain (MBD) protein capture for genome-wide DNA methylation analysis reveal CpG sequence coverage bias. Epigenetics 6, 34-44.
100. Newbold, R. R., Padilla-Banks, E. & Jefferson, W. N. (2006). Adverse effects of the model environmental estrogen diethylstilbestrol are transmitted to subsequent generations. Endocrinology 147, S11-S17.
101. Nguyen, T., Kuo, C., Nicholl, M. B., Sim, M. S., Turner, R. R., Morton, D. L. & Hoon, D. S. (2011). Downregulation of microRNA-29c is associated with hypermethylation of tumorrelated genes and disease outcome in cutaneous melanoma. Epigenetics 6, 388-394.
102. Palmer, J. R., Wise, L. A., Hatch, E. E., Troisi, R., Titus-Ernstoff, L., Strohsnitter, W., Kaufman, R., Herbst, A. L., Noller, K. L., Hyer, M. & Hoover, R. N. (2006). Prenatal diethylstilbestrol exposure and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 15, 1509-1514.
103. Park, S. Y., Kwon, H. J., Lee, H. E., Ryu, H. S., Kim, S. W., Kim, J. H., Kim, I. A., Jung, N., Cho, N. Y. & Kang, G. H. (2011). Promoter CpG island hypermethylation during breast cancer progression. Virchows Arch 458, 73-84.
104. Perou, C. M., Sorlie, T., Eisen, M. B., Van De, R. M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., Fluge, O., Pergamenschikov, A., Williams, C., Zhu, S. X., Lonning, P. E., Borresen-Dale, A. L., Brown, P. O. & Botstein, D. (2000). Molecular portraits of human breast tumours. Nature 406, 747-752.
105. Pokholok, D. K., Harbison, C. T., Levine, S., Cole, M., Hannett, N. M., Lee, T. I., Bell, G. W., Walker, K., Rolfe, P. A., Herbolsheimer, E., Zeitlinger, J., Lewitter, F., Gifford, D. K. & Young, R. A. (2005). Genome-wide map of nucleosome acetylation and methylation in yeast. Cell 122, 517-527.
106. Prat, A. & Perou, C. M. (2011). Deconstructing the molecular portraits of breast cancer. Mol Oncol 5, 5-23.
107. Puppe, J., Drost, R., Liu, X., Joosse, S. A., Evers, B., Cornelissen-Steijger, P., Nederlof, P., Yu, Q., Jonkers, J., Van Lohuizen, M. & Pietersen, A. M. (2009). BRCA1-deficient mammary tumor cells are dependent on EZH2 expression and sensitive to Polycomb Repressive Complex 2-inhibitor 3-deazaneplanocin A. Breast Cancer Res 11:R63.
108. Radisky, D. C. (2011). miR-200c at the nexus of epithelial-mesenchymal transition, resistance to apoptosis, and the breast cancer stem cell phenotype. Breast Cancer Res 13, 110.
109. Rijnkels, M., Kabotyanski, E., Montazer-Torbati, M. B., Beauvais, C. H., Vassetzky, Y., Rosen, J. M. & Devinoy, E. (2010). The epigenetic landscape of mammary gland development and functional differentiation. J Mammary Gland Biol Neoplasia 15, 85-100.
110. Rodenhiser, D. I., Andrews, J., Kennette, W., Sadikovic, B., Mendlowitz, A., Tuck, A. B. & Chambers, A. F. (2008). Epigenetic mapping and functional analysis in a breast cancer metastasis model using whole-genome promoter tiling microarrays. Breast Cancer Res 10:R62.
111. Rodriguez, J., Frigola, J., Vendrell, E., Risques, R. A., Fraga, M. F., Morales, C., Moreno, V., Esteller, M., Capella, G., Ribas, M. & Peinado, M. A. (2006). Chromosomal instability correlates with genome-wide DNA demethylation in human primary colorectal cancers. Cancer Res 66, 8462-9468.
112. Rollins, R. A., Haghighi, F., Edwards, J. R., Das, R., Zhang, M. Q., Ju, J. & Bestor, T. H. (2006). Large-scale structure of genomic methylation patterns. Genome Res 16, 157-163.
113. Ronneberg, J. A., Fleischer, T., Solvang, H. K., Nordgard, S. H., Edvardsen, H., Potapenko, I., Nebdal, D., Daviaud, C., Gut, I., Bukholm, I., Naume, B., Borresen-Dale, A. L., Tost, J. & Kristensen, V. (2011). Methylation profiling with a panel of cancer related genes: association with estrogen receptor, TP53 mutation status and expression subtypes in sporadic breast cancer. Mol Oncol 5, 61-76.
114. Rosenfeld, C. S. (2010). Animal models to study environmental epigenetics. Biol Reprod 82, 473-488.
115. Sato, K., Fukata, H., Kogo, Y., Ohgane, J., Shiota, K. & Mori, C. (2009). Neonatal exposure to diethylstilbestrol alters expression of DNA methyltransferases and methylation of genomic DNA in the mouse uterus. Endocr J 56, 131-139.
116. Scelfo, R. A., Schwienbacher, C., Veronese, A., Gramantieri, L., Bolondi, L., Querzoli, P., Nenci, I., Calin, G. A., Angioni, A., Barbanti-Brodano, G. & Negrini, M. (2002). Loss of methyla tion at chromosome 11p15.5 is common in human adult tumors. Oncogene 21, 2564-2572.
117. Sengupta, K., Camps, J., Mathews, P., Barenboim-Stapleton, L., Nguyen, Q. T., Difilippantonio, M. J. & Ried, T. (2008). Position of human chromosomes is conserved in mouse nuclei indicating a species-independent mechanism for maintaining genome organization. Chromosoma 117, 499-509.
118. Sharma, D., Saxena, N. K., Davidson, N. E. & Vertino, P. M. (2006). Restoration of tamoxifen sensitivity in estrogen receptor-negative breast cancer cells: tamoxifen-bound reactivated ER recruits distinctive corepressor complexes. Cancer Res 66, 6370-6378.
119. Shi, M., Liu, D., Duan, H., Shen, B. & Guo, N. (2010). Metastasis-related miRNAs, active players in breast cancer invasion, and metastasis. Cancer Metastasis Rev 29, 785-799.
120. Shinozaki, M., Hoon, D. S., Giuliano, A. E., Hansen, N. M., Wang, H. J., Turner, R. & Taback, B. (2005). Distinct hypermethylation pro file of primary breast cancer is associated with sentinel lymph node metastasis. Clin Cancer Res 11, 2156-2162.
121. Shukla, V., Coumoul, X., Lahusen, T., Wang, R. H., Xu, X., Vassilopoulos, A., Xiao, C., Lee, M. H., Man, Y. G., Ouchi, M., Ouchi, T. & Deng, C. X. (2010). BRCA1 affects global DNA methylation through regulation of DNMT1. Cell Res 20, 1201-1215.
122. Silva, J. M., Boczek, N. J., Berres, M. W., Ma, X. & Smith, D. I. (2011). LSINCT5 is over expressed in breast and ovarian cancer and affects cellular proliferation. RNA Biol 8, 496-505.
123. Simonis, M., Klous, P., Splinter, E., Moshkin, Y., Willemsen, R., De Wit, E., Van Steensel, B. & De Laat, W. (2006). Nuclear organization of active and inactive chromatin domains uncovered by chromosome conformation capture-on-chip (4 C). Nat Genet 38, 1348-1354.
124. Sioud, M. (2009). Targeted delivery of antisense oligonucleotides and siRNAs into mammalian cells. Methods Mol Biol 487, 61-82.
125. Sorlie, T., Perou, C. M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M. B., Van De, R. M., Jeffrey, S. S., Thorsen, T., Quist, H., Matese, J. C., Brown, P. O., Botstein, D., Eystein, L. P. & Borresen-Dale, A. L. (2001). Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 98, 10869-10874.
126. Stefansson, O. A., Jonasson, J. G., Olafsdottir, K., Hilmarsdottir, H., Olafsdottir, G., Esteller, M., Johannsson, O. T. & Eyfjord, J. E. (2011). CpG island hypermethylation of BRCA1 and loss of pRb as co-occurring events in basal/triple-negative breast cancer. Epigenetics 6, 638-649.
127. Strahl, B. D. & Allis, C. D. (2000). The language of covalent histone modifications. Nature 403, 41-45.
128. Suijkerbuijk, K. P., Van Diest, P. J. & Van Der, W. E. (2011). Improving early breast cancer detection: focus on methylation. Ann Oncol 22, 24-29.
129. Sun, Z., Asmann, Y. W., Kalari, K. R., Bot, B., Eckel-Passow, J. E., Baker, T. R., Carr, J. M., Khrebtukova, I., Luo, S., Zhang, L., Schroth, G. P., Perez, E. A. & Thompson, E. A. (2011). Integrated analysis of gene expression, CpG island methylation, and gene copy number in breast cancer cells by deep sequencing. PLoS ONE 6, e17490.
130. Taft, R. J., Pang, K. C., Mercer, T. R., Dinger, M. & Mattick, J. S. (2010). Non-coding RNAs: regulators of disease. J Pathol 220, 126-139.
131. Tan, J., Yang, X., Zhuang, L., Jiang, X., Chen, W., Lee, P. L., Karuturi, R. K., Tan, P. B., Liu, E. T. & Yu, Q. (2007). Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells. Genes Dev 21, 1050-1063.
132. Tsang, D. P. & Cheng, A. S. (2011). Epigenetic regulation of signaling pathways in cancer: role of the histone methyltransferase EZH2. J Gastroenterol Hepatol 26, 19-27.
133. Valastyan, S., Chang, A., Benaich, N., Reinhardt, F. & Weinberg, R. A. (2011). Activation of miR-31 function in already-established metastases elicits metastatic regression. Genes Dev 25, 646-659.
134. Van Der Auwera, I., Bovie, C., Svensson, C., Trinh, X. B., Limame, R., Van Dam, P., Van Laere, S. J., Van Marck, E. A., Dirix, L. Y. & Vermeulen, P. B. (2010). Quantitative methylation profiling in tumor and matched morphologically normal tissues from breast cancer patients. BMC Cancer 10:97.
135. Vandenberg, L. N., Maffini, M. V., Sonnenschein, C., Rubin, B. S. & Soto, A. M. (2009). Bisphenol-A and the great divide: a review of controversies in the field of endocrine disruption. Endocr Rev 30, 75-95.
136. Weber, B., Stresemann, C., Brueckner, B. & Lyko, F. (2007). Methylation of human microRNA genes in normal and neoplastic cells. Cell Cycle 6, 1001-1005.
137. Welsh, J. (1994). Induction of apoptosis in breast cancer cells in response to vitamin D and antiestrogens. Biochem Cell Biol 72, 537-545.
138. Weng, Y. I., Hsu, P. Y., Liyanarachchi, S., Liu, J., Deatherage, D. E., Huang, Y. W., Zuo, T., Rodriguez, B., Lin, C. H., Cheng, A. L. & Huang, T. H. (2010). Epigenetic influences of low-dose bisphenol A in primary human breast epithelial cells. Toxicol Appl Pharmacol 248, 111-121.
139. Wicha, M. S., Liu, S. & Dontu, G. (2006). Cancer stem cells: an old idea-A paradigm shift. Cancer Res 66, 1883-1890.
140. Widschwendter, M. & Jones, P. A. (2002). DNA methylation and breast carcinogenesis. Oncogene 21, 5462-5482.
141. Wu, Y., Crawford, M., Yu, B., Mao, Y., Nana-Sinkam, S. P. & Lee, L. J. (2011). MicroRNA delivery by cationic lipoplexes for lung cancer therapy. Mol Pharm 8, 1381-1389.
142. Xu, X., Gammon, M. D., Zhang, Y., Cho, Y. H., Wetmur, J. G., Bradshaw, P. T., Garbowski, G., Hibshoosh, H., Teitelbaum, S. L., Neugut, A. I., Santella, R. M. & Chen, J. (2010). Gene promoter methylation is associated with increased mortality among women with breast cancer. Breast Cancer Res Treat 121, 685-692.
143. Yan, P. S., Venkataramu, C., Ibrahim, A., Liu, J. C., Shen, R. Z., Diaz, N. M., Centeno, B., Weber, F., Leu, Y. W., Shapiro, C. L., Eng, C., Yeatman, T. J. & Huang, T. H. (2006). Mapping geographic zones of cancer risk with epigenetic biomarkers in normal breast tissue. Clin Cancer Res 12, 6626-6636.
144. Zhang, Y. & Reinberg, D. (2001). Transcription regulation by histone methylation: interplay between different covalent modifications of the core histone tails. Genes Dev 15, 2343-2360.
145. Zhao, H., Shen, J., Medico, L., Wang, D., Ambrosone, C. B. & Liu, S. (2010). A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer. PLoS ONE 5, e13735.